SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
StockNews.AI • 589 days
Low Materiality0/10
Information
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves...
Original sourceAI Summary
Pomerantz LLP investigates potential securities fraud by PTC Therapeutics, Inc. Negative opinion on drug Translarna led to 11.77% stock price drop for PTC. Pomerantz LLP known for securities litigation, fighting for victims of fraud. Investors advised to contact Danielle Peyton for more information.
Market-Moving
- Pomerantz LLP investigates potential securities fraud by PTC Therapeutics, Inc.
- Negative opinion on drug Translarna led to 11.77% stock price drop for PTC.
- Pomerantz LLP known for securities litigation, fighting for victims of fraud.
Key Facts
- Pomerantz LLP investigates potential securities fraud by PTC Therapeutics, Inc.
- Negative opinion on drug Translarna led to 11.77% stock price drop for PTC.
- Pomerantz LLP known for securities litigation, fighting for victims of fraud.
- Investors advised to contact Danielle Peyton for more information.